Trial · NCT02168309
Oral Nifedipine Versus Oral Labetalol
NCT02168309, Not applicable, Completed, Cedars-Sinai Medical Center; results first posted 2017-12-13
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Oral Nifedipine Versus Oral Labetalol. Trials, record NCT02168309. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02168309
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Oral Nifedipine Versus Oral Labetalol
- NCT number
- NCT02168309
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 50 participants, actual
- Lead sponsor
- Cedars-Sinai Medical Center
- Conditions
- Severe Postpartum Hypertension
- Interventions
- Labetalol, Nifedipine
- First posted
- 2014-06-20
- Last updated
- 2017-12-13
- Results first posted
- 2017-12-13
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time (Hours) to Attain Sustained Blood Pressure Goal After Treatment Initiated With Antihypertensive Medication | 24 hours | Primary outcome |
| Secondary | Total Length of Hospital Stay in Days | 0-10 days | Secondary outcome |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Time (Hours) to Attain Sustained Blood Pressure Goal After Treatment Initiated With Antihypertensive Medication | 24 hours | hours | MEAN | |
| SECONDARY | Total Length of Hospital Stay in Days | 0-10 days | days | MEAN |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time (Hours) to Attain Sustained Blood Pressure Goal After Treatment Initiated With Antihypertensive Medication | Labetalol | 37.6 | Standard Deviation 32.5 | hours | |
| Time (Hours) to Attain Sustained Blood Pressure Goal After Treatment Initiated With Antihypertensive Medication | Nifedipine | 38.2 | Standard Deviation 27.6 | hours | |
| Total Length of Hospital Stay in Days | Labetalol | 4.0 | Standard Deviation 1.5 | days | |
| Total Length of Hospital Stay in Days | Nifedipine | 4.3 | Standard Deviation 2.3 | days |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Labetalol | 25 | |
| Overall Study | STARTED | Nifedipine | 25 | |
| Overall Study | COMPLETED | Labetalol | 25 | |
| Overall Study | COMPLETED | Nifedipine | 25 | |
| Overall Study | NOT COMPLETED | Labetalol | 0 | |
| Overall Study | NOT COMPLETED | Nifedipine | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Labetalol | ||
| Total, all-cause mortality | Nifedipine | ||
| Total, other adverse events | Labetalol | 0 | 25 |
| Total, other adverse events | Nifedipine | 0 | 25 |
| Total, serious adverse events | Labetalol | 0 | 25 |
| Total, serious adverse events | Nifedipine | 0 | 25 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 27786578 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Labetalol vs Nifedipine: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02168309
GET https://conductscience.org/api/trials/v1/NCT02168309/registered